Levaquin users slap J&J with $800M RICO suit, claiming pharma giant hid serious side effects

Emily Wasserman

Johnson & Johnson is facing yet another lawsuit over its antibiotic from people who claim that the company hid tied to the drug. The latest legal action comes a couple of months after an FDA panel flagged problems associated with the entire class of antibiotics and voted to change the meds' labels.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS